CenterBook Partners’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
CenterBook Partners's ADMA Position: Q3 2026 in Review
CenterBook Partners increased its ADMA Biologics (ADMA) stake by 1.8% in Q3 2026, buying an estimated $13.2K and bringing the position to 81,607 shares worth $819K. The position accounts for 0.04% of the portfolio, ranked #500.
CenterBook Partners first reported a position in ADMA in Q3 2022 and has held it in 5 quarters since. The position peaked at $1.6M in Q2 2025. 329 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- CenterBook Partners held 81,607 shares of ADMA Biologics worth $819K as of Q3 2026.
- CenterBook Partners bought 1,432 ADMA Biologics shares in Q3 2026, an estimated $13.2K.
- ADMA Biologics made up 0.04% of CenterBook Partners's portfolio in Q3 2026, its #500 holding.
- CenterBook Partners first reported a position in ADMA Biologics in Q3 2022 and has held it in 5 quarters since.
- CenterBook Partners's ADMA Biologics position peaked at $1.6M in Q2 2025.
- 329 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.